Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > The time is now

<< Previous

Bullboard Posts

Next >>

Comment by Actuarialon Jun 08, 2021 12:22pm

130 Views

Post# 33348133

RE:RE:RE:RE:RE:The time is now

The question everyone should ask himself is: would you still hold your shares if there is no deal in 12 months? In light of ATE has not decided on lowest effective dose, a deal is not in sight yet. My view on ATE is long run but not short term speculation. It depends on how you view the fact of a p2/3 being required. negative side: it requires more time and money; positive side: it will bring us safer profile. I see it be strong positive - it is worth for the longer wait. GLTA longs!

MrMugsy wrote:

woundedknee wrote: So Mugsy, I naively wrote a post early this morning wondering why the share price was floundering and admitted that I didn't know. I also stated that at least Dan was not selling his shares and come to find out , HE WAS, along with Walter Macnee. This after going above the 200 day moving average. So we drop right back below the very next day. Maybe Dan should get a salary increase rather than selling shares out of the blue. I do not know What Dan's salary is, but I would imangine it's ample to say the least. This may not be the real reason for the drop, but it doesn't help. Information like this can change a persons view on a company very quickly. Deja Vu all over again.
It's time for a review of leadership imo.

With respect to Dan's share sale ... you're beating a dead horse as we've already been there a bunch. The only difference would be if you had a chat with Dan and gave us an update. Much appreciated if you would.

Shares aren't moving on that news - the shares aren't really moving as volume is almost non-existent.

If you want Dan out ... then vote him out at the AGM. Don't let me stand in your way - I think you have bigger hurdles in your way than my votes.

Anyway ... the answer is ... we need deals and I think that's what they are working on. We need excitement to come back and hopefully that's what P3 will offer. With deals and P3 coming ... we should have what we need for a NASDAQ listing. If we don't get the deals ... then we wait.

Now you're caught up Wounded !